| 臺大學術典藏 |
2022-03-31T06:37:33Z |
Lipid changes in extrapulmonary organs and serum of rats after chronic exposure to ambient fine particulate matter
|
Lin C.-Y.; Chen W.-L.; Chen T.-Z.; Lee S.-H.; Liang H.-J.; Chou C.C.-K.; Tang C.-H.; TSUN-JEN CHENG |
| 臺大學術典藏 |
2022-03-29T06:59:56Z |
Lipid changes in extrapulmonary organs and serum of rats after chronic exposure to ambient fine particulate matter
|
CHING-YU LIN; Chen W.-L.; Chen T.-Z.; Lee S.-H.; Liang H.-J.; Chou C.C.-K.; Tang C.-H.; Cheng T.-J. |
| 臺大學術典藏 |
2021-05-24T13:07:44Z |
Lipid changes in extrapulmonary organs and serum of rats after chronic exposure to ambient fine particulate matter
|
CHING-YU LIN; WEN-LING CHEN; Chen, Ting Zhen; Lee, Sheng Han; Liang, Hao Jan; Chou, Charles C.K.; Tang, Chuan Ho; TSUN-JEN CHENG |
| 臺大學術典藏 |
2022-01-11T07:07:08Z |
Lipid changes in extrapulmonary organs and serum of rats after chronic exposure to ambient fine particulate matter
|
Charlene Wu; TSUN-JEN CHENG |
| 中國文化大學 |
2016-02 |
Lipid Content and Fatty Acid Composition in Taiwan Avocados (Persea americana Mill)
|
Teng, SW (Teng, Shen-Wen); Hsiung, TC (Hsiung, Tung-Chuan); Shyr, JJ (Shyr, Jeng-Jung); Wakana, A (Wakana, Akira) |
| 國立臺灣大學 |
1994 |
Lipid Content of Cerumen from Normal Dogs and Otitis Canine Ear
|
黃慧璧; Fixter, L. M.; Little, C. J. L.; Huang, Hui-Pi; Fixter, L. M.; Little, C. J. L. |
| 國立臺灣大學 |
1994-05 |
Lipid content of cerumen from normal dogs and those with otitis externa
|
Huang, HP; Fixter, LM; Little, CJL |
| 淡江大學 |
20050615 |
Lipid for biodiesel production from attached growth Chlorella vulgaris biomass cultivating in fluidized bed bioreactor packed with polyurethane foam material
|
Ainur-Assyakirin, Mohd-Sahib;Lim, Jun-Wei;Lam, Man-Kee;Uemura, Yoshimitsu;Isa, Mohamed Hasnain;Ho, Chii-Dong;Kutty, Shamsul Rahman Mohamed;Wong, Chung-Yiin;Rosli, Siti-Suhailah |
| 國立臺灣大學 |
2000 |
Lipid Formation and Fine Structure of Marine Microalga Isochrysis sp. CCMP 1324.
|
劉清標; Liu, Ching Piao |
| 國立臺灣大學 |
2010 |
Lipid Formulations of Amphotericin B and Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis Reply
|
孫幸筠; SUN, HSIN-YUN |
| 國立臺灣大學 |
2009 |
Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis
|
孫幸筠; SUN, HSIN-YUN |
| 臺大學術典藏 |
2018-09-10T07:19:59Z |
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis
|
Sun, H.-Y. and Alexander, B.D. and Lortholary, O. and Dromer, F. and Forrest, G.N. and Lyon, G.M. and Somani, J. and Gupta, K.L. and Del Busto, R. and Pruett, T.L. and Sifri, C.D. and Limaye, A.P. and John, G.T. and Klintmalm, G.B. and Pursell, K. and Stosor, V. and Morris, M.I. and Dowdy, L.A. and Munoz, P. and Kalil, A.C. and Garcia-Diaz, J. and Orloff, S. and House, A.A. and Houston, S. and Wray, D. and Huprikar, S. and Johnson, L.B. and Humar, A. and Razonable, R.R. and Husain, S. and Singh, N.; HSIN-YUN SUN |
| 臺大學術典藏 |
2009 |
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis
|
Forrest G.N.; Dromer F.; Lortholary O.; Alexander B.D.; HSIN-YUN SUN; Houston S.; House A.A.; Orloff S.; Garcia-Diaz J.; Kalil A.C.; Munoz P.; Lyon G.M.; Somani J.; Gupta K.L.; Del Busto R.; Pruett T.L.; Sifri C.D.; Limaye A.P.; John G.T.; Klintmalm G.B.; Pursell K.; Stosor V.; Morris M.I.; Dowdy L.A.; Wray D.; Huprikar S.; Johnson L.B.; Humar A.; Razonable R.R.; Husain S.; Singh N. |
| 臺大學術典藏 |
2018-09-10T14:51:58Z |
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials
|
Tebas, P. and Sension, M. and Arribas, J. and Duiculescu, D. and Florence, E. and Hung, C.-C. and Wilkin, T. and Vanveggel, S. and Stevens, M. and Deckx, H.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T03:22:38Z |
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials
|
Tebas P.; Sension M.; Arribas J.; Duiculescu D.; Florence E.; CHIEN-CHING HUNG; Wilkin T.; Vanveggel S.; Stevens M.; Deckx H. |
| 臺大學術典藏 |
2022-09-09T05:50:01Z |
Lipid lowering in primary prevention: The lower is better, but where to settle?
|
WEI-SHIUNG YANG |
| 國立成功大學 |
2018-09 |
Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients
|
Li;Yi-Heng;Chao;Ting-Hsing;Liu;-Yen, Ping;Ueng;Kwo-Chang;Yeh;Hung-I |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2018-09-10T18:02:50Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? �V Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T. and Yin, W.-H. and Tseng, W.-K. and Lin, F.-J. and Yeh, H.-I. and Chen, J.-W. and Wu, Y.-W. and Wu, C.-C.; FANG-JU LIN; YEN-WEN WU |
| 嘉南藥理大學 |
2021 |
Lipid Metabolism and its Mechanism Triggered by Supercritical CO2 Extract of Adlay (Coix lacryma-jobi var. ma-yuen (Rom. Caill.) Stapf) Bran in High-Fat Diet Induced Hyperlipidemic Hamsters
|
Huang, Chiao-Chih; Lin, Tzu-Ching; Liu, Chiung-Hui; Hu, Hao-Chun; Yu, Szu-Yin; Wu, Shu-Jing; Yen, Ming-Hong; Tsai, Yi-Hong; Chang, Fang-Rong |
| 國立成功大學 |
2016-06 |
Lipid metabolism during WSSV infection in shrimp
|
Cheng, Cheng-Shun; Wang, Han-Ching |
| 臺北醫學大學 |
2003 |
Lipid metabolism in hypercholesterolemic rats affected by feeding cholesterol-free diets containing different amounts of undialyzed soybean protein fraction.
|
陳俊榮; Chen; JR; Chiou; SF; Suetsuna; K; Yang; HY; and Yang; SC |
